Cargando…

Effectiveness of Sublingual Buprenorphine and Fentanyl Pump in Controlling Pain After Open Cholecystectomy

BACKGROUND: The proper management of postoperative pain improves patients’ quality of life, accelerates early postoperative recovery, shortens hospitalization period, and reduces medical costs. This study aimed to compare the effectiveness of intravenous fentanyl pump and sublingual buprenorphine ta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Norozi, Vadood, Ghazi, Ahmad, Amani, Firouz, Bakhshpoori, Parya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kowsar 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438705/ https://www.ncbi.nlm.nih.gov/pubmed/34540635 http://dx.doi.org/10.5812/aapm.113909

Ejemplares similares

Fentanyl Sublingual Spray for Breakthrough Pain in Cancer Patients
por: Zeppetella, Giovambattista
Publicado: (2013)

Single-dose fentanyl sublingual spray for breakthrough cancer pain
por: Taylor, Donald R
Publicado: (2013)

Sublingual Buprenorphine: A Feasible Alternative for Treating Breakthrough Chronic Pain
por: Nair, Abhijit S, et al.
Publicado: (2019)

The effect of preoperative sublingual buprenorphine on postoperative pain after lumbar discectomy: A randomized controlled trial
por: Kiabi, Farshad Hassanzadeh, et al.
Publicado: (2021)

Sublingual buprenorphine for acute renal colic pain management: a double-blind, randomized controlled trial
por: Payandemehr, Pooya, et al.
Publicado: (2014)

Dosing considerations with transdermal formulations of fentanyl and buprenorphine for the treatment of cancer pain
por: Skaer, Tracy L
Publicado: (2014)

Rifampicin decreases exposure to sublingual buprenorphine in healthy subjects
por: Hagelberg, Nora M., et al.
Publicado: (2016)

Case Report: Buprenorphine-precipitated fentanyl withdrawal treated with high-dose buprenorphine
por: Bormann, Nicholas L., et al.
Publicado: (2023)

Sublingual Buprenorphine/Naloxone and Multi-Modal Management for High-Risk Chronic Pain Patients
por: Kaski, Shane, et al.
Publicado: (2021)

Transdermal buprenorphine and fentanyl patches in cancer pain: a network systematic review
por: Ahn, Jin Seok, et al.
Publicado: (2017)

Efficacy of Buprenorphine/Naloxone Rapidly Dissolving Sublingual Tablets (BNX-RDT) After Switching From BNX Sublingual Film
por: Gunderson, Erik W., et al.
Publicado: (2016)

Sublingual Buprenorphine Efficacy in Renal Colic Pain Relief: A Randomized Placebo-Controlled Clinical Trial
por: Mozafari, Javad, et al.
Publicado: (2017)

Comparison of sublingual buprenorphine and intravenous morphine in reducing bone metastases associated pain in cancer patients
por: Jamalian, Seyed Mohammad, et al.
Publicado: (2019)

Modeling buprenorphine reduction of fentanyl-induced respiratory depression
por: Olofsen, Erik, et al.
Publicado: (2022)

Individual and structural correlates of willingness for intravenous buprenorphine treatment among people who inject sublingual buprenorphine in France
por: Mezaache, Salim, et al.
Publicado: (2021)

Effects of Age Among Elderly Cancer Patients on Breakthrough Pain Management with Sublingual Fentanyl Tablets
por: Guitart, Jordi, et al.
Publicado: (2019)

New developments in the management of opioid dependence: focus on sublingual buprenorphine–naloxone
por: Soyka, Michael
Publicado: (2015)

In vitro and in vivo evaluation of a sublingual fentanyl wafer formulation
por: Lim, Stephen CB, et al.
Publicado: (2013)

Oxycodone vs. Fentanyl Patient-Controlled Analgesia after Laparoscopic Cholecystectomy
por: Hwang, Boo-Young, et al.
Publicado: (2014)

Pharmacokinetic–Pharmacodynamic Modeling of the Effectiveness and Safety of Buprenorphine and Fentanyl in Rats
por: Yassen, Ashraf, et al.
Publicado: (2007)

Differences between Transdermal Fentanyl and Buprenorphine in the Elderly Hospice Patients
por: Golčić, Marin, et al.
Publicado: (2018)

Methadone, Buprenorphine, Oxycodone, Fentanyl and Tramadol in Multiple Postmortem Matrices
por: Havig, Stine Marie, et al.
Publicado: (2021)

Fulminant hepatic failure after intravenous injection of sublingual buprenorphine in a patient with hepatitis C
por: French, Janine, et al.
Publicado: (2015)

Correction to: Individual and structural correlates of willingness for intravenous buprenorphine treatment among people who inject sublingual buprenorphine in France
por: Mezaache, Salim, et al.
Publicado: (2021)

An Evaluation of Total Disintegration Time for Three Different Doses of Sublingual Fentanyl Tablets in Patients with Breakthrough Pain
por: Nalamachu, Srinivas
Publicado: (2013)

Effect of naloxone on intravenous fentanyl patient-controlled analgesia after laparoscopic cholecystectomy
por: Zheng, Jun, et al.
Publicado: (2016)

Postoperative respiratory depression in patients on sublingual buprenorphine: a retrospective cohort study for comparison between postoperative continuation and discontinuation of buprenorphine
por: Komatsu, Ryu, et al.
Publicado: (2022)

Effect of fentanyl versus buprenorphine on the pupil size in phacoemulsification cataract surgery
por: Anaraki, Abdolreza Najafi, et al.
Publicado: (2012)

Fentanyl but Not Morphine or Buprenorphine Improves the Severity of Necrotizing Acute Pancreatitis in Rats
por: Bálint, Emese Réka, et al.
Publicado: (2022)

Reddit discussions about buprenorphine associated precipitated withdrawal in the era of fentanyl
por: Spadaro, Anthony, et al.
Publicado: (2022)

Feasibility and efficacy of sublingual buprenorphine tablets in managing acute postoperative pain after elective breast cancer surgeries: A series of 10 cases
por: Sumanth, D Krishna, et al.
Publicado: (2019)

Post-operative Analgesia in Opioid Dependent Patients: Comparison of Intravenous Morphine and Sublingual Buprenorphine
por: Alizadeh, Shaabanali, et al.
Publicado: (2015)

Perioperative opioid requirements of patients receiving sublingual buprenorphine-naloxone: a case series
por: Martin, Yvette N., et al.
Publicado: (2019)

2198: Gender differences in the pharmacology of buprenorphine sublingual tablets in Hispanics/Latinos: An underrepresented population
por: Ivelisse Santiago, Darlene, et al.
Publicado: (2018)

Extended-release pharmacotherapy for opioid use disorder (EXPO): protocol for an open-label randomised controlled trial of the effectiveness and cost-effectiveness of injectable buprenorphine versus sublingual tablet buprenorphine and oral liquid methadone
por: Marsden, John, et al.
Publicado: (2022)

A comparison of oral controlled-release morphine and oxycodone with transdermal formulations of buprenorphine and fentanyl in the treatment of severe pain in cancer patients
por: Nosek, Krzysztof, et al.
Publicado: (2017)

The Analgesic Effect of Nefopam with Fentanyl at the End of Laparoscopic Cholecystectomy
por: Lee, Ju Hwan, et al.
Publicado: (2013)

Breakthrough Pain Management with Sublingual Fentanyl Tablets in Patients with Cancer: Age Subgroup Analysis of a Multicenter Prospective Study
por: Guitart, Jordi, et al.
Publicado: (2017)

Efficacy and Safety of Sublingual Fentanyl Tablets in Breakthrough Cancer Pain Management According to Cancer Stage and Background Opioid Medication
por: Guitart, Jordi, et al.
Publicado: (2018)

Pharmaceutical and pharmacokinetic characterization of a novel sublingual buprenorphine/naloxone tablet formulation in healthy volunteers
por: Fischer, Andreas, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ahj55t13reaae3ktb29mg0bqp3